VIEWPOINT
Commentaries on Viewpoint: Human skeletal muscle wasting in hypoxia: a matter of hypoxic dose?
INFLUENCE OF THE BETWEEN-SUBJECTS AND BETWEEN-HYPOXIC CONDITIONS VARIABILITY IN OXIDATIVE STRESS
TO THE EDITOR: The authors of the Viewpoint (2) propose that a cut-off point for initiation of hypoxia-induced muscle wasting is 5,000 km·h. Although they employ a valuable new metric, incorporating elevation and total exposure time, we previously suggested that it might be better to quantify the hypoxic stimuli by using "saturation hours" (4) . This is particularly important given that both (de)saturation and oxidative/nitrosative stress responses to hypoxia are highly variable between individuals and also differ between the types of hypoxia (i.e., hypobaric vs. normobaric) (3) . It is well established that the level of desaturation importantly modulates oxidative stress and, moreover, that augmented oxidative stress levels significantly contribute to disuse muscle atrophy by increasing protein oxidation and accelerating muscle protein breakdown (5) . In addition, reactive oxygen species were shown to stabilize HIF-1␣, independently of hypoxic stimulus, which likely plays a role in downregulation of muscle mass, as outlined in the Viewpoint (2). The close relationship between oxidative/nitrosative stress and muscle atrophy observed in cachexia and sarcopenia patients (1) lends further support to this notion. The individual variability in responses to hypoxia must therefore be taken into account to enhance our understanding of the mechanism underlying hypoxia-related muscle wasting. To conclude, it seems unlikely that a critical hypoxic threshold for muscle wasting could be defined solely on the "external" hypoxic dose, without accounting for the between-individual variability in desaturation (i.e., hypoxic stimuli) and/or oxidative/nitrosative stress responses. (1) argue that the severity of muscle atrophy incurred at high altitude is dependent on the combined effect of duration and degree of hypoxia exposure, or "hypoxic dose" (1) . We do see a limitation of this concept, as it implies that someone residing in Leuven (altitude: 28 m) for 10 years would be subjected to a hypoxic dose of 2,454 km·h and incur 5% atrophy. Although the authors wrote that "it is unknown which parameter, altitude, or time spent at altitude is most decisive in the overall metric of hypoxic dose," our illustration suggests that altitude is the prime determinant. This is further supported by the cut-off point at 4,000 m in a plot of the degree of atrophy vs. altitude (using the data in Table 1 ), whereas there was no clear relationship with duration of altitude residence. This cut-off point is likely related to the shape of the hemoglobin dissociation curve, where the oxygen tension at 4,000 m is such that physiologically significant arterial hemoglobin desaturation occurs (2) . We acknowledge that one cannot entirely dismiss the importance of duration of hypoxic exposure, simply because skeletal muscle atrophy can only be noticed some time after net protein breakdown is initiated. However, muscle atrophy will not continue indefinitely, but will reach a new steady state (how otherwise can Tibetans still have muscle?). Finally, other adaptations than atrophy, such as an increase in hematocrit and capillarization, serve to attenuate muscle tissue hypoxia and atrophy (3) during residence at altitude. hypoxia is developed through three different stages: alarming stage, resistance/adaptation stage, and de-adaptation stage. In general, the skeletal muscle is anatomically and physiologically overcompensated during the adaptive stage. However, human skeletal muscle wasting in hypoxia mentioned in this paper is actually evident as a de-adaptive response. In other words, high-altitude or prolonged hypoxic stress is overwhelming and the body reaches the de-adaptation stage.
However, the authors make a good point that the dose of hypoxic stress does matter (2) . We previously revealed that PO 2 cycling has a protective effect on diaphragmatic skeletal muscle via the attenuation of reactive oxygen species and the increase of fatigue resistance (5). In human study, hypoxic exposure during high-altitude training results in increased V O 2max in elite endurance athletes (3). Therefore, the dose and duration of hypoxia exposure play a pivotal role in regulating skeletal muscle mass. In contrast to chronic hypoxic exposure, intermittent acute hypoxic exposure combined with resistance exercise could potentially delay muscle wasting and promote muscle growth (1) . Future approaches should focus on how to optimize the dose and duration of hypoxia exposure to maximize the skeletal muscle adaptive response without exacerbating skeletal muscle atrophy.
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A DOSE OF 5,000 KM·H OF SEVERE HYPOXIA (AT > 5,000 M ALTITUDE) IS PROBABLY REQUIRED TO INDUCE SKELETAL MUSCLE WASTING IN HUMANS
TO THE EDITOR: We appreciate the authors' Viewpoint (1) regarding the concept that a hypoxic dose of at least 5,000 km·h is necessary to induce skeletal muscle wasting in humans. We agree that both the time of exposure and the level of altitude are critical for inducing a loss of muscle mass. However, in our point of view, a dose of at least 5,000 km·h with a minimal altitude of 5,000 m is probably required. For instance, 8-wk exposure to 4,100 m altitude (i.e.,~5,500 km·h) did not lead to a significant decrease in skeletal muscle fiber cross sectional area (FCSA) in humans (2) . In contrast, 40 days at an average altitude of~5,500 m (i.e.,~5,300 km·h) reduced muscle FCSA by~25% (3). Athletes undergoing training camps usually stay at a lower altitude of~2,500 -3,000 m, but not for a period long enough to reach an hypoxic dose of 5,000 km·h. Still, a dose of at least 5,000 km·h at 2,500 -3,000 m altitude (i.e., at least 83 and 69 days of exposure, respectively) is likely insufficient to induce significant muscle atrophy because of the limited hypoxic stress. Several physiological factors have been proposed to explain the loss of body weight and muscle mass during prolonged exposure to severe hypoxia, including a reduction of energy intake, nutrient malabsorption, physical inactivity, and parameters related to mountaineering (4). However, loss of appetite and the resulting decreased caloric intake is probably the predominant cause for the muscle wasting at Ͼ 5,000 m altitude (5).
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A LESSER MUSCLE HYPERTROPHIC RESPONSE TO RESISTANCE TRAINING BELOW THE HYPOXIC DOSE OF 5,000 KM·H
TO THE EDITOR: D'Hulst and Deldicque (1) suggest a minimum hypoxic exposure of 5,000 km·h for hypoxia-induced muscle atrophy to develop. We (4) found a reduced hypertrophic response to resistance training in chronic hypoxia. Young men performed strength training of the elbow flexors for 1 mo, once at 5,050 m and once with an identical load at sea level. They were in energy balance, lived in comfortable conditions (Ev-K2-CNR Pyramid, Lobuche, Nepal), and consumed a similar diet at altitude and at sea level. NMRI quantified muscle cross-sectional area increased less at altitude compared with sea level (11.3 vs. 17.7%), whereas muscle-specific tension did not vary. The hypoxic dose of 3,600 km·h suggests that the effect of hypoxia on muscle protein anabolism and catabolism balance is already influenced below 5,000 km·h. As D'Hulst and Deldicque mention, the combination of time and altitude is not necessarily uniform. Furthermore, diet, living conditions, exercise, sleep, fatigue, or nonaltitude illness may be confounding factors (5) . Muscle maintenance in hypoxia thus still remains to be better described. The verb "wasting" has a strong negative connotation, and the title of this Viewpoint suggests that muscle loss in hypoxia implies squandering of precious tissue (1) . As acknowledged by D'Hulst and Deldicque, there are good reasons to not discard the opposite hypothesis. The reduction in the volume of metabolic costly tissue may actually serve a physiological purpose. In their reviews, Murray and Montgomery (3; see also comment in 2) proposed that the loss of body mass at altitude helps the organism to survive in oxygen deprived conditions. TO THE EDITOR: We welcome the suggestion by D'Hulst and Deldicque (1) that both duration of exposure and elevation influence the occurrence and extent of muscle wasting in hypoxia. The application of the hypoxic dose metric, proposed by Garvican-Lewis et al. (2) , is an interesting proposition but, in our view, too preliminary given the paucity of studies, low subject numbers, and interindividual variability in response. The studies highlighted collectively suggest that muscle wasting occurs only above a threshold average elevation of around 5,000 m and reliably so above this point. Any dependence upon duration of exposure is harder to establish. Sojourns above 5,000 m are rarely short in duration, and within those studies hitherto performed above this altitude (durations 35-75 days), there is no clear association between dose and extent of wasting. Exposure duration is key to many aspects of muscle remodeling at altitude (3). Indeed, the stabilization of HIF1␣ vs HIF2␣, and thus their relative contributions to the cellular hypoxia response, is time dependent (4). However, muscle wasting is likely also influenced systemically by appetitesuppressing effects of hypoxia (5), which may also be time dependent and would probably introduce further interindividual variation. The duration component must also reflect any delay between a molecular response to hypoxia/caloric deficit and the detection of measureable morphological changes, unless molecular techniques are employed. The authors make the important point that future studies should be designed to precisely elucidate the relative contributions of duration vs elevation to muscle wasting. We agree, and reserve judgement on a hypoxic dose threshold.
